Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 69, Issue 6
RSPO2 abnormal transcripts result from read-through in liver tumours with high ß-catenin activation and CTNNB1 mutations
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Responses
Article
metrics
Alerts
PDF
PostScript
Letter
RSPO2
abnormal transcripts result from read-through in liver tumours with high ß-catenin activation and
CTNNB1
mutations
Online download statistics by month:
Online download statistics by month: June 2019 to January 2021
Abstract
Full
Pdf
Jun 2019
1058
67
33
Jul 2019
423
27
10
Aug 2019
223
15
0
Sep 2019
178
6
5
Oct 2019
115
5
4
Nov 2019
82
6
3
Dec 2019
112
3
3
Jan 2020
88
12
3
Feb 2020
130
8
1
Mar 2020
50
10
1
Apr 2020
21
4
2
May 2020
210
53
14
Jun 2020
47
44
17
Jul 2020
68
2
3
Aug 2020
29
2
2
Sep 2020
61
2
2
Oct 2020
76
10
13
Nov 2020
54
5
7
Dec 2020
53
2
0
Jan 2021
60
5
2
Total
3138
288
125
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?